DALVANCE

NDC 57970-100 · Allergan, Inc.

Generic nameDalbavancin

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DALBAVANCIN HYDROCHLORIDE

Strength500 mg/25mL

Pharmacologic classLipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]

Marketing categoryNDA

Packages

57970-100-01 — 1 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL

Billed under HCPCS

J0875 — Injection, dalbavancin, 5 mg Medicare Part B payment limit (ASP + 6%): $9.44

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0480-3325 — Dalbavancin, 65219-120 — DALBAVANCIN HYDROCHLORIDE, 70069-830 — Dalbavancin, 71288-034 — Dalbavancin, 71839-144 — dalbavancin, 81298-2390 — dalbavancin hydrochloride

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources